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Abstract: This brief commentary aims to focus on the urgency of further clinical research on
phytotherapy in dentistry, and, noteworthy, to propose, for the first time, to the best of our knowledge,
the term “odontonutraceuticals” to identify those phytochemicals relevant for the prevention and
the treatment of oral diseases. A valuable impact is expected on nutritional, dental and biomedical
sciences, suggesting the use of the suffix "odonto-" to define a specific field of nutraceutical research.
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As the incidence of nutrition-related diseases is increasing greatly, along with the scientific and
media’s interest for dietary styles and herbal medicine, nutritional-based complementary clinical
approaches acquire, today, considerable relevance. A current example comes from “Expo Milano 2015”,
the non-commercial Universal Exposition, which will be mainly focused on the problems related to
nutrition and health, and on the food resources of our planet. To date, abundant preclinical literature
and epidemiological data exist in supporting beneficial effects of some plant-derived compounds,
namely phytochemicals, towards general well-being, as well as in the prevention and treatment of a
number of diseases [1].
Dentistry is not exempt from this topic. Due to the recent interest for a phytotherapeutic approach
to dentistry [2,3], we would like, here, to introduce, to the best of our knowledge for the first time, the
term “odontonutraceuticals”, in order to identify those phytochemicals relevant for the prevention and
the management of oral diseases. “Odonto” arises from the Greek word odòntos for “tooth”, while the
term nutraceuticals refers to bioactive phytochemicals, which can provide health-promoting effects [4].
Since ancient times, plants have been an exemplary source of pharmaceuticals and a plethora
of preclinical and epidemiological studies has documented the potential of nutraceuticals in the
prevention of the major chronic and degenerative diseases, by virtue of their cardioprotective,
neuroprotective and anticancer properties [5]. Similarly, (odonto)nutraceuticals may play a significant
role in the care of dental patients, as many oral diseases include complex and multifactorial disorders,
often involving multiple deregulated pathways. In these terms, odontonutraceuticals can represent
promising and pleiotropic phytotherapeutic agents in dentistry, because of their ability to regulate
different molecular and biochemical targets [6]. Interestingly, recent findings suggest that plant extracts,
composed by a number of bioactive components, are more effective than individual compounds,
because of additive and/or synergistic effects. Relevant examples of odontonutraceuticals include
green tea, grape and cocoa seed extracts, rich in polyphenols, particularly catechins, a group of
flavonoids, and proanthocyanidins (Figure 1) [7,8]. Nonetheless, Aloe vera-based gels showed
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interesting properties in mucosal wound healing, even with a certain capacity to promote pain control
in oral lichen planus patients, as reported by a Cochrane review on this topic [9].
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Figure 1. Polyphenols relevant for oral health: (1) (+)-catechin and (2) epigallocatechin-3-gallate are 
flavan-3-ols, a group of flavonoids, whereas (3) proanthocyanidins arise from the oligomerization or 
polymerization of flavan-3-ol units. 
However, despite the promising preclinical evidences and the presence of relevant 
epidemiological and clinical data, further research on nutraceuticals in dentistry still needs to be 
carried out, mainly to better elucidate the potential role of confounding factors and compound 
pharmacokinetics [2]. In particular, the low oral bioavailability of phytochemicals remains, to date, 
the major drawback of this approach. After oral administration, to achieve the effective 
concentrations at the target sites, the bioactive components of ingested food have to pass a series of 
mucosal barriers, at gastro-enteric level, and resist, in active form, to biotransformation by phase I 
and II enzymes, including the hepatic first-pass metabolism, as well as by bacteria of the intestinal 
microbial flora. In this view, the efficacy of nutraceuticals can be greatly improved by innovative 
local drug delivery systems [1], which can enhance their transmucosal absorption. Buccal mucosa 
represents a recognized and very attractive topical route of administration, for both local action and 
systemic absorption of (odonto)nutraceuticals. Many pharmaceutical formulations have been 
recently developed to successfully produce more and more muco-adhesive carriers in order to 
enhance absorption of phytochemicals, including nanoparticle-enriched films, hydrogels, sprays 
and patches [1]. These carriers would improve the topical activity of odontonutraceuticals on oral 
cavity, as well as their systemic effects, due to increased absorption. 
To conclude, odontonutraceuticals are expected to represent promising agents towards 
multi-factorial oral diseases and to acquire more and more importance within the scientific/clinical 
scenario. Their efficacy, in dental patients, needs to be supported by further evidence and, in these 
terms, we strongly emphasize a systematic approach to verify phytochemical efficacy, rising the 
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However, despite the promising preclinical evidences and the presence of relevant epidemiological
and clinical data, further research on nutraceuticals in dentistry still needs to be carried out, mainly
to better elucidate the potential role of confounding factors and compound pharmacokinetics [2]. In
particular, the low oral bioavailability of phytochemicals remains, to date, the major drawback of
this approach. After oral administration, to achieve the effective concentrations at the target sites,
the bioactive components of ingested food have to pass a series of mucosal barriers, at gastro-enteric
level, and resist, in active form, to biotransformation by phase I and II enzymes, including the hepatic
first-pass metabolism, as well as by bacteria of the intestinal microbial flora. In this view, the efficacy
of nutraceuticals can be greatly improved by innovative local drug delivery systems [1], which can
enhance their transmucosal absorption. Buccal mucosa represents a recognized and very attractive
topical route of administration, for both local action and systemic absorption of (odonto)nutraceuticals.
Many pharmaceutical formulations have been recently developed to successfully produce more
and more muco-adhesive carriers in order to enhance absorption of phytochemicals, including
nanoparticle-enriched films, hydrogels, sprays and patches [1]. These carriers would improve
the topical activity of odontonutraceuticals on oral cavity, as well as their systemic effects, due to
increased absorption.
To conclude, odontonutraceuticals are expected to represent promising agents towards
multi-factorial oral diseases and to acquire more and more importance within the scientific/clinical
scenario. Their efficacy, in dental patients, needs to be supported by further evidence and, in these
terms, we strongly emphasize a systematic approach to verify phytochemical efficacy, rising the
pyramid of evidence-based dentistry, where the preclinical research is the essential prerequisite for
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clinical studies, which, in turn, represent the apex of evidence [10]. Blind randomized clinical trials,
designed to compare odontonutraceuticals with current gold-standard treatments, wherever possible,
will greatly improve both scientific knowledge and clinical relevance.
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